Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients

Transplant International

Volumn 16, Issue 10, 2003, Pages 726-729

  Reddy, Srikanth P ^a   Handa, Ashok ^a   Tan, Liamchin ^b   Devaney, Andrea ^b   Hughes, David ^a   Mason, Phillip ^b   Friend, Peter J ^a,b   Darby, Christopher R ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cytomegalovirus; Prophylaxis; Renal; Transplantation; Valaciclovir

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; GANCICLOVIR; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISOLONE; VALACICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; PRODRUGS; REOPERATION; RETROSPECTIVE STUDIES; TISSUE DONORS; VALINE;

EID: 0242558146     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-003-0612-4     Document Type: Article

References (13)

1. Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA (1975) The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293:1109
2. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. (1992) Symptomatic cytomegalovirus disease in the cytomegalovirus antibody-seropositive renal transplant recipient treated with OKT3. Transplantation 53:68
3. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. (1995) Pre-emptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med 123:18
4. Conti DJ, Freed BM, Gruber SA, Lemper N (1994) Prophylaxis of primary CMV disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg 129:44
5. Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) A randomized placebo-controlled trial of oral aciclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320:1381
6. Flechner SM, Avery RK, Fisher R, et al. (1998) A prospective control trial of oral aciclovir versus oral ganciclovir for CMV prophylaxis in high-risk kidney transplant recipients. Transplantation 66:1682
7. Lowance D, Neumayer HH, Legendre CM, et al. (1999) Valaciclovir for the prevention of cytomegalovirus disease after renal transplantation. N Engl J Med 340:1462
8. Legendre CM, Norman DJ, Keating MR, Maclaine GDH, Grant DM (2000) Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation. Transplantation 70:1463
9. Couchoud C, Cucherat M, Haugh M, Pouteil-Noble C (1998) Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation. Transplantation 65:6417
10. Ostermann M, Macphee I, Chang R (2001) Prophylaxis of cytomegalovirus in renal transplantation. Nephrol Dial Transplant 16:2276
11. Sund F, Wahlberg J, Eriksson BM (2001) CMV disease in CMV-mismatched renal transplant recipients with prophylactic low-dose valaciclovir. J Clin Virol 23:107
12. Hirata M, Terasaki P, Cho YW (1996) Cytomegalovirus antibody status and renal transplantation: 1987-1994. Transplantation 62:34
13. Dickenmann MJ, Cathomas G, Steiger J, Mihatsch MJ, Thiel G, Tamm M (2001) CMV infection and graft rejection in renal transplantation. Transplantation 71:764